跳至主要内容
临床试验/CTRI/2020/11/028986
CTRI/2020/11/028986招募中未知

Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis- A Randomized Controlled Trial

Institute of Liver and Biliary Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Patients with cirrhosis of liver with recurrent ascites.
  • 2) Patients with age from 18-70 years

排除标准

  • 1.Renal failure (Creatinine >1.5mg/dl)
  • 2.Recent Gastrointestinal bleeding within 7 days
  • 3.Spontaneous bacterial Peritonitis
  • 4.Patients with organic nephropathy ( as defined by IAC)
  • 5.Patients with Cardiovascular disease or chronic obstructive pulmonary disease
  • 6.Systemic arterial hypertension ( >160/90mmhg)
  • 7.Presence of hepatocellular carcinoma (outside Milan criteria)( or portal vein thrombosis
  • 8.Budd-Chiari Syndrome
  • 9.Patients with active sepsis
  • 10.Pregnancy
  • 11.Patients with hepatic encephalopathy
  • 12.No use of drugs affecting systemic hemodynamics 7 days prior to enrolment (except beta-blockers)
  • 13.Patients with serum albumin >3 gm
  • 14.Refusal to participate
  • 15.Known or suspected hypersensitivity to albumin
  • 16.Prior TIPS
  • 17.Post liver or kidney transplantation
  • 18.Patients enrolled in other clinical trials
  • 19.Extrahepatic malignancy

研究者

相似试验